BeiGene Collaborated with InnoRNA to Discover Novel mRNA-LNP Therapies
Shots:
- InnoRNA will receive an up front & and additional fees upon achievement of development, regulatory & commercial milestones along with royalties for the mRNA-LNP research collaboration programs where BeiGene will obtain an exclusive development & commercialization rights globally
- BeiGene will gain a non-exclusive license for the LNP technology platform for which InnoRNA will additionally receive upfront & is eligible to receive milestones to support internal discovery efforts
- The collaboration b/w InnoRNA & BeiGene will advance & support their research in mRNA therapies along with securing critical, proprietary delivery tools
Ref: Bussinesswire | Image: BeiGene
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
